These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Antinuclear antibodies and lupus due to phenothiazines in 600 hospitalized patients]. Gallien M; Schnetzler JP; Morin J Ann Med Psychol (Paris); 1975 Feb; 1(2):237-48. PubMed ID: 9021 [No Abstract] [Full Text] [Related]
9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine. Tada M; Shirakawa K; Matsuoka N; Mutoh S Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255 [TBL] [Abstract][Full Text] [Related]
10. Two cases of deep vein thrombosis associated with antipsychotic drug use. Matsumoto M; Konno T; Tamba K; Abe T; Kato S; Kajii E Psychiatry Clin Neurosci; 2004 Aug; 58(4):450-1. PubMed ID: 15298663 [No Abstract] [Full Text] [Related]
11. [Sensory disorders arising during neuroleptic therapy]. Rovinskaia SA; Revva LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):905-9. PubMed ID: 6106339 [TBL] [Abstract][Full Text] [Related]
12. Haloperidol versus chlorpromazine for schizophrenia. Leucht C; Kitzmantel M; Chua L; Kane J; Leucht S Cochrane Database Syst Rev; 2008 Jan; (1):CD004278. PubMed ID: 18254045 [TBL] [Abstract][Full Text] [Related]
13. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Hermesh H; Aizenberg D; Weizman A; Lapidot M; Mayor C; Munitz H Br J Psychiatry; 1992 Aug; 161():254-7. PubMed ID: 1355693 [TBL] [Abstract][Full Text] [Related]
14. Resolution of chlorpromazine-induced cutaneous pigmentation following substitution with levomepromazine or other neuroleptics. Bloom D; Krishnan B; Thavundayil JX; Lal S Acta Psychiatr Scand; 1993 Mar; 87(3):223-4. PubMed ID: 8096668 [TBL] [Abstract][Full Text] [Related]
15. In vivo study of the mutagenicity of biperidine, pipotiazine, chlorpromazine, and haloperidol. Smith M; de Souza MA; Pugliese S; Mari Jde J Am J Med Genet; 1996 Apr; 67(2):238. PubMed ID: 8723058 [No Abstract] [Full Text] [Related]
16. Combined therapy with low-potency neuroleptic levomepromazine as an adjunct to haloperidol for agitated patients with acute exacerbation of schizophrenia. Higashima M; Takeda T; Nagasawa T; Hirao N; Oka T; Nakamura M; Kitamura M; Koshino Y Eur Psychiatry; 2004 Sep; 19(6):380-1. PubMed ID: 15363480 [No Abstract] [Full Text] [Related]
17. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone. Meibach RC Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283 [No Abstract] [Full Text] [Related]
18. Levomepromazine versus chlorpromazine in treatment-resistant schizophrenia: a double-blind randomized trial. Lal S; Thavundayil JX; Nair NP; Annable L; Ng Ying Kin NM; Gabriel A; Schwartz G J Psychiatry Neurosci; 2006 Jul; 31(4):271-9. PubMed ID: 16862245 [TBL] [Abstract][Full Text] [Related]
19. [Priapism in neuroleptic therapy]. Eikmeier G Nervenarzt; 1987 Dec; 58(12):771-2. PubMed ID: 3431614 [TBL] [Abstract][Full Text] [Related]
20. [A case of malignant neuroleptic syndrome. Case report]. Martius P; Hüther R; Zilker T Nervenarzt; 1996 May; 67(5):418-21. PubMed ID: 9005355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]